The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Tepotinib in Solid Tumors Harboring MET Alterations
Official Title: A Phase II Study of Tepotinib in Patients With Solid Cancers Harboring c-MET Amplification or Exon 14 Mutation Who Progressed After Standard Treatment for Advanced/Metastatic Disease
Study ID: NCT04647838
Brief Summary: The aim of this study is to understand efficacy of tepotinib in patients with solid cancers harbouring c-MET amplification or exon 14 mutation who progressed after standard treatment for metastatic disease.
Detailed Description: This study is a basket trial with two strata(NSCLC and other cancer). If MET exon 14 skipping mutation or MET amplification(copy number gain ≥6.0 ) is detected by NGS method, then confirmation of genetic findings by Molecular Steering Committee will be followed. Patient can participate in this trial after confirmation of genetic analysis and reviewing other inclusion/exclusion criteria.
Minimum Age: 19 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Chonnam National University Hwasun Hospital, Hwasun, Chonnam, Korea, Republic of
Chungbuk National University Hospital, Cheongju-si, Chungcheongbuk-do, Korea, Republic of
Dankook University Hospital, Cheonan, , Korea, Republic of
Keimyung University Dongsan Hospital, Daegu, , Korea, Republic of
Konyang University Hospital, Daejeon, , Korea, Republic of
National Cancer Center, Goyang-si, , Korea, Republic of
Hallym University Dongtan Sacred Heart Hospital, Hwaseong-si, , Korea, Republic of
Gachon University Gil Medical Center, Incheon, , Korea, Republic of
The Catholic University of Korea Incheon St. Marry Hospital, Incheon, , Korea, Republic of
Gyeongsang National University Hospital, Jinju, , Korea, Republic of
Inje University Haeundae Pain Hospital, Pusan, , Korea, Republic of
Kosin University Gaspel Hospital, Pusan, , Korea, Republic of
Seoul National University Bundang Hospital, Seongnam-si, , Korea, Republic of
Chungang University Hospital, Seoul, , Korea, Republic of
Gangnam Severance Hospital, Seoul, , Korea, Republic of
Inje University Sanggye Paik Hospital, Seoul, , Korea, Republic of
Korea University Anam Hospital, Seoul, , Korea, Republic of
Korea University Guro Hospital, Seoul, , Korea, Republic of
Samsung Medical Center, Seoul, , Korea, Republic of
Seoul National University Hospital, Seoul, , Korea, Republic of
Severance Hospital, Seoul, , Korea, Republic of
Pusan National University Yangsan Hospital, Yangsan, , Korea, Republic of
Name: Ki Hyeong Lee, M.D.
Affiliation: Chungbuk National University Hospital
Role: STUDY_CHAIR